Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
1,2,3-Trilinoleoyl glycerol is a triacylglycerol that contains linoleic acid (Item Nos. 90150 | 90150.1 | 21909) at the sn-1, sn-2, and sn-3 positions. It reduces production of oxygen-derived free radicals in leukocytes.1 1,2,3-Trilinoleoyl glycerol (1 µM) reduces mitochondrial swelling and deformation induced by ischemia and reperfusion injury in perfused rat hearts. In vivo, 1,2,3-trilinoleoyl glycerol (1 mg/kg) reduces the incidence rate and duration of ventricular tachycardia, as well as infarct size in a rat model of coronary artery ligation-induced ischemia and reperfusion injury.2
WARNING This product is not for human or veterinary use.
1. Trilinolein preserves mitochondria ultrastructure in isolated rat heart subjected to global ischemia through antioxidant activity as measured by chemiluminescence. Pharmacology 52(4), 216-225 (1996).
2. Trilinolein reduces infarct size and suppresses ventricular arrhythmias in rats subjected to coronary ligation. Pharmacology 51(2), 118-126 (1995).